tradingkey.logo

Pediatrix Medical Group Inc

MD
20.890USD
+0.070+0.34%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
1.79BMarktkapitalisierung
10.86KGV TTM

Pediatrix Medical Group Inc

20.890
+0.070+0.34%

mehr Informationen über Pediatrix Medical Group Inc Unternehmen

Pediatrix Medical Group, Inc. is a provider of physician services, including newborn, maternal-fetal, and other pediatric subspecialty care. The Company’s affiliated clinicians provide services to women, babies and children across the continuum of care, both in hospital settings and office-based practices. Its specialties include obstetrics, maternal-fetal medicine and neonatology, complemented by pediatric subspecialties. It offers specialized and critical care services through approximately 4,400 affiliated physicians and other clinicians. It provides neonatal clinical care, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications. The Company provides maternal-fetal and obstetrical medical care to expectant mothers experiencing complicated pregnancies primarily in areas where its affiliated neonatal physicians practice.

Pediatrix Medical Group Inc Informationen

BörsenkürzelMD
Name des UnternehmensPediatrix Medical Group Inc
IPO-datumSep 20, 1995
CEOOrdan (Mark S)
Anzahl der mitarbeiter2150
WertpapierartOrdinary Share
GeschäftsjahresendeSep 20
Addresse1301 Concord Terrace
StadtSUNRISE
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl33323
Telefon19543840175
Websitehttps://www.pediatrix.com/
BörsenkürzelMD
IPO-datumSep 20, 1995
CEOOrdan (Mark S)

Führungskräfte von Pediatrix Medical Group Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Mark S. Ordan
Mr. Mark S. Ordan
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
302.81K
-23000.00%
Ms. Mary Ann E. Moore
Ms. Mary Ann E. Moore
Executive Vice President, Chief Administrative Officer, General Counsel, Company Secretary
Executive Vice President, Chief Administrative Officer, General Counsel, Company Secretary
279.23K
+35904.00%
Mr. Guy P. Sansone
Mr. Guy P. Sansone
Lead Independent Director
Lead Independent Director
79.75K
+11427.00%
Mr. Michael A. Rucker
Mr. Michael A. Rucker
Independent Director
Independent Director
59.10K
-10478.00%
Mrs. Sylvia Jean Young
Mrs. Sylvia Jean Young
Independent Director
Independent Director
40.62K
+11427.00%
Ms. Laura A. Linynsky
Ms. Laura A. Linynsky
Independent Director
Independent Director
32.23K
-10000.00%
Ms. Shirley A. Weis
Ms. Shirley A. Weis
Independent Director
Independent Director
29.09K
-6933.00%
Mr. Thomas A. Mceachin
Mr. Thomas A. Mceachin
Independent Director
Independent Director
--
--
Mr. John M. Starcher, Jr., Esq.
Mr. John M. Starcher, Jr., Esq.
Independent Director
Independent Director
--
--
Dr. James D. (Jim) Swift, M.D.
Dr. James D. (Jim) Swift, M.D.
Director
Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Mark S. Ordan
Mr. Mark S. Ordan
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
302.81K
-23000.00%
Ms. Mary Ann E. Moore
Ms. Mary Ann E. Moore
Executive Vice President, Chief Administrative Officer, General Counsel, Company Secretary
Executive Vice President, Chief Administrative Officer, General Counsel, Company Secretary
279.23K
+35904.00%
Mr. Guy P. Sansone
Mr. Guy P. Sansone
Lead Independent Director
Lead Independent Director
79.75K
+11427.00%
Mr. Michael A. Rucker
Mr. Michael A. Rucker
Independent Director
Independent Director
59.10K
-10478.00%
Mrs. Sylvia Jean Young
Mrs. Sylvia Jean Young
Independent Director
Independent Director
40.62K
+11427.00%
Ms. Laura A. Linynsky
Ms. Laura A. Linynsky
Independent Director
Independent Director
32.23K
-10000.00%

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Neonatology and other pediatric subspecialties
1.67B
83.00%
Maternal-fetal medicine
342.20M
17.00%
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Neonatology and other pediatric subspecialties
1.67B
83.00%
Maternal-fetal medicine
342.20M
17.00%

Aktionärsstatistik

Aktualisiert: Fri, Feb 6
Aktualisiert: Fri, Feb 6
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
13.92%
The Vanguard Group, Inc.
12.41%
Victory Capital Management Inc.
4.80%
State Street Investment Management (US)
4.11%
Dimensional Fund Advisors, L.P.
3.96%
Andere
60.79%
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
13.92%
The Vanguard Group, Inc.
12.41%
Victory Capital Management Inc.
4.80%
State Street Investment Management (US)
4.11%
Dimensional Fund Advisors, L.P.
3.96%
Andere
60.79%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
54.68%
Investment Advisor/Hedge Fund
32.45%
Hedge Fund
7.79%
Research Firm
2.84%
Individual Investor
2.13%
Pension Fund
1.83%
Bank and Trust
0.54%
Family Office
0.49%
Sovereign Wealth Fund
0.08%

Institutionelle Beteiligung

Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
553
86.11M
100.27%
-9.44M
2025Q3
537
85.20M
99.23%
-3.30M
2025Q2
529
80.91M
92.92%
-19.92M
2025Q1
527
86.06M
100.19%
-15.16M
2024Q4
517
90.19M
105.15%
-17.55M
2024Q3
511
92.24M
107.52%
-21.18M
2024Q2
508
93.58M
111.19%
-6.96M
2024Q1
500
90.86M
108.12%
-7.93M
2023Q4
497
88.44M
105.22%
-9.09M
2023Q3
495
90.77M
108.10%
-7.21M
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
BlackRock Institutional Trust Company, N.A.
11.96M
13.92%
-69.89K
-0.58%
Sep 30, 2025
The Vanguard Group, Inc.
10.83M
12.61%
-92.36K
-0.85%
Sep 30, 2025
Victory Capital Management Inc.
4.13M
4.8%
+968.55K
+30.67%
Sep 30, 2025
State Street Investment Management (US)
3.53M
4.11%
+41.26K
+1.18%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
3.40M
3.96%
+81.55K
+2.46%
Sep 30, 2025
American Century Investment Management, Inc.
2.68M
3.12%
+751.11K
+38.88%
Sep 30, 2025
Fidelity Management & Research Company LLC
2.20M
2.56%
-209.50K
-8.69%
Sep 30, 2025
Geode Capital Management, L.L.C.
2.17M
2.52%
+168.46K
+8.43%
Sep 30, 2025
D. E. Shaw & Co., L.P.
2.02M
2.35%
+443.57K
+28.11%
Sep 30, 2025
Charles Schwab Investment Management, Inc.
1.45M
1.69%
+179.30K
+14.14%
Sep 30, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
Brandes US Small-Mid Cap Value ETF
2.08%
Euclidean Fundamental Value ETF
1.89%
State Street SPDR S&P Health Care Services ETF
1.47%
ETC 6 Meridian Small Cap Equity ETF
1.18%
Inspire Fidelis Multi Factor ETF
1.05%
Cambria Value and Momentum ETF
0.96%
Invesco S&P SmallCap Health Care ETF
0.89%
Burney US Factor Rotation ETF
0.59%
Distillate Small/Mid Cash Flow ETF
0.55%
Royce Quant Small-Cap Quality Value ETF
0.5%
Mehr Anzeigen
Brandes US Small-Mid Cap Value ETF
Anteil2.08%
Euclidean Fundamental Value ETF
Anteil1.89%
State Street SPDR S&P Health Care Services ETF
Anteil1.47%
ETC 6 Meridian Small Cap Equity ETF
Anteil1.18%
Inspire Fidelis Multi Factor ETF
Anteil1.05%
Cambria Value and Momentum ETF
Anteil0.96%
Invesco S&P SmallCap Health Care ETF
Anteil0.89%
Burney US Factor Rotation ETF
Anteil0.59%
Distillate Small/Mid Cash Flow ETF
Anteil0.55%
Royce Quant Small-Cap Quality Value ETF
Anteil0.5%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
KeyAI